PubMed

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK.

Lancet Oncol. 2009 Nov 6. [Epub ahead of print]PMID: 19897418 [PubMed - as supplied by publisher]Related articles

A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors.

Cohen RB, Jones SF, Aggarwal C, von Mehren M, Cheng J, Spigel DR, Greco FA, Mariani M, Rocchetti M, Ceruti R, Comis S, Laffranchi B, Moll J, Burris HA.

Clin Cancer Res. 2009 Nov 1;15(21):6694-701. Epub 2009 Oct 13.PMID: 19825950 [PubMed - in process]Related articles

Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin.

Karp DD, Pollak MN, Cohen RB, Eisenberg PD, Haluska P, Yin D, Lipton A, Demers L, Leitzel K, Hixon ML, Terstappen LW, Garland L, Paz-Ares LG, Cardenal F, Langer CJ, Gualberto A.

J Thorac Oncol. 2009 Nov;4(11):1397-403.PMID: 19745765 [PubMed - in process]Related articles

Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers.

Lewis NL, Lewis LD, Eder JP, Reddy NJ, Guo F, Pierce KJ, Olszanski AJ, Cohen RB.

J Clin Oncol. 2009 Nov 1;27(31):5262-9. Epub 2009 Sep 8.PMID: 19738123 [PubMed - indexed for MEDLINE]Related articles

Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation.

Lango MN, Egleston B, Ende K, Feigenberg S, D'Ambrosio DJ, Cohen RB, Ahmad S, Nicolaou N, Ridge JA.

Head Neck. 2009 Aug 19. [Epub ahead of print]PMID: 19693946 [PubMed - as supplied by publisher]Related articles

Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study.

Leong S, Cohen RB, Gustafson DL, Langer CJ, Camidge DR, Padavic K, Gore L, Smith M, Chow LQ, von Mehren M, O'Bryant C, Hariharan S, Diab S, Fox NL, Miceli R, Eckhardt SG.

J Clin Oncol. 2009 Sep 10;27(26):4413-21. Epub 2009 Aug 3.PMID: 19652058 [PubMed - indexed for MEDLINE]Related articles

Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer.

Borghaei H, Alpaugh K, Hedlund G, Forsberg G, Langer C, Rogatko A, Hawkins R, Dueland S, Lassen U, Cohen RB.

J Clin Oncol. 2009 Sep 1;27(25):4116-23. Epub 2009 Jul 27.PMID: 19636016 [PubMed - indexed for MEDLINE]Related articles

Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.

Vidal L, Tsao MS, Pond GR, Cohen EE, Cohen RB, Chen EX, Agulnik M, Hotte S, Winquist E, Laurie S, Hayes DN, Ho J, Dancey J, Siu LL.

Head Neck. 2009 Aug;31(8):1006-12.PMID: 19309723 [PubMed - indexed for MEDLINE]Related articles

Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors.

Oostendorp RL, Loftiss J, Goel S, Smith DA, Dar MM, Witteveen PO, Cohen RB, Lewis LD, Kurian S, Patnaik A, Rosing H, Beijnen JH, Voest EE, Burris H, J.

Int J Clin Pharmacol Ther. 2009 Mar;47(3):195-206.PMID: 19281729 [PubMed - indexed for MEDLINE]Related articles

An open-label clinical trial evaluating safety and pharmacokinetics of two dosing schedules of panitumumab in patients with solid tumors.

Stephenson JJ, Gregory C, Burris H, Larson T, Verma U, Cohn A, Crawford J, Cohen RB, Martin J, Lum P, Yang X, Amado RG.

Clin Colorectal Cancer. 2009 Jan;8(1):29-37.PMID: 19203894 [PubMed - indexed for MEDLINE]Related articles

Effects of food on the relative bioavailability of lapatinib in cancer patients.

Koch KM, Reddy NJ, Cohen RB, Lewis NL, Whitehead B, Mackay K, Stead A, Beelen AP, Lewis LD.

J Clin Oncol. 2009 Mar 10;27(8):1191-6. Epub 2009 Feb 2.PMID: 19188677 [PubMed - indexed for MEDLINE]Related articles

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.

Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW, Blajman CR, Mickiewicz EA, Frenette GP, Plinar LF, Cohen RB, Steinbrenner LM, Freue JM, Gorbunova VA, Tjulandin SA, Raez LE, Adkins DR, Tishler RB, Roessner MR, Haddad RI; TAX 324 Study Group.

Ann Oncol. 2009 May;20(5):921-7. Epub 2009 Jan 29.PMID: 19179556 [PubMed - indexed for MEDLINE]Related articles

Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression.

Cohen RB, Boggio PS, Fregni F.

Depress Anxiety. 2009;26(7):682-8.PMID: 19170101 [PubMed - in process]Related articles

New agents in the treatment for malignancies of the salivary and thyroid glands.

Mehra R, Cohen RB.

Hematol Oncol Clin North Am. 2008 Dec;22(6):1279-95, xi. Review.PMID: 19010274 [PubMed - indexed for MEDLINE]Related articles

The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck.

Mehra R, Cohen RB, Burtness BA.

Clin Adv Hematol Oncol. 2008 Oct;6(10):742-50. Review.PMID: 18997665 [PubMed - indexed for MEDLINE]Related articlesFree article

Promising survival in patients with recurrent non-small cell lung cancer treated with docetaxel and gemcitabine in combination as second-line therapy.

Huang CH, Millenson MM, Sherman EJ, Borghaei H, Mintzer DM, Cohen RB, Staddon AP, Seldomridge J, Treat OJ, Tuttle H, Ruth KJ, Langer CJ.

J Thorac Oncol. 2008 Sep;3(9):1032-8.PMID: 18758307 [PubMed - indexed for MEDLINE]Related articles

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.

Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB.

J Clin Oncol. 2008 Oct 10;26(29):4708-13. Epub 2008 Jun 9.PMID: 18541897 [PubMed - indexed for MEDLINE]Related articles

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies.

von Mehren M, Schilder RJ, Cheng JD, Temmer E, Cardoso TM, Renshaw FG, Bayever E, Zannikos P, Yuan Z, Cohen RB.

Ann Oncol. 2008 Oct;19(10):1802-9. Epub 2008 May 22.PMID: 18497430 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.

Adjei AA, Cohen RB, Franklin W, Morris C, Wilson D, Molina JR, Hanson LJ, Gore L, Chow L, Leong S, Maloney L, Gordon G, Simmons H, Marlow A, Litwiler K, Brown S, Poch G, Kane K, Haney J, Eckhardt SG.

J Clin Oncol. 2008 May 1;26(13):2139-46. Epub 2008 Apr 7.PMID: 18390968 [PubMed - indexed for MEDLINE]Related articlesFree article

EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.

Mehra R, Cohen RB, Harari PM.

Curr Oncol Rep. 2008 Mar;10(2):176-84. Review.PMID: 18377832 [PubMed - indexed for MEDLINE]Related articles

Clinical application of EGFR inhibitors in head and neck squamous cell cancer.

Astsaturov I, Cohen RB, Harari PM.

Cancer Treat Res. 2008;139:135-52. Review. No abstract available. PMID: 18236715 [PubMed - indexed for MEDLINE]Related articles

EGFR-targeting monoclonal antibodies in head and neck cancer.

Astsaturov I, Cohen RB, Harari P.

Curr Cancer Drug Targets. 2007 Nov;7(7):650-65. Review.PMID: 18045070 [PubMed - indexed for MEDLINE]Related articles

A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500).

Pandya KJ, Dahlberg S, Hidalgo M, Cohen RB, Lee MW, Schiller JH, Johnson DH; Eastern Cooperative Oncology Group (E1500).

J Thorac Oncol. 2007 Nov;2(11):1036-41.PMID: 17975496 [PubMed - indexed for MEDLINE]Related articles

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB, Spaulding M, Tishler RB, Roth B, Viroglio Rdel C, Venkatesan V, Romanov I, Agarwala S, Harter KW, Dugan M, Cmelak A, Markoe AM, Read PW, Steinbrenner L, Colevas AD, Norris CM Jr, Haddad RI; TAX 324 Study Group.

N Engl J Med. 2007 Oct 25;357(17):1705-15.PMID: 17960013 [PubMed - indexed for MEDLINE]Related articlesFree article

The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium.

Harari PM, Cohen RB, Raben D, Myers JN, Vokes EE, Weber RS, Ang KK.

Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S1-3. No abstract available. PMID: 17848271 [PubMed - indexed for MEDLINE]Related articles

Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.

Agulnik M, Cohen EW, Cohen RB, Chen EX, Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, Brown S, Pond GR, Lorimer I, Daneshmand M, Ho J, Tsao MS, Siu LL.

J Clin Oncol. 2007 Sep 1;25(25):3978-84.PMID: 17761983 [PubMed - indexed for MEDLINE]Related articles

Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.

Jänne PA, von Pawel J, Cohen RB, Crino L, Butts CA, Olson SS, Eiseman IA, Chiappori AA, Yeap BY, Lenehan PF, Dasse K, Sheeran M, Bonomi PD.

J Clin Oncol. 2007 Sep 1;25(25):3936-44.PMID: 17761977 [PubMed - indexed for MEDLINE]Related articles

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

Curran D, Giralt J, Harari PM, Ang KK, Cohen RB, Kies MS, Jassem J, Baselga J, Rowinsky EK, Amellal N, Comte S, Bonner JA.

J Clin Oncol. 2007 Jun 1;25(16):2191-7. Erratum in: J Clin Oncol. 2007 Aug 20;25(24):3790. PMID: 17538164 [PubMed - indexed for MEDLINE]Related articles

Unexpected dementia following prophylactic cranial irradiation for small cell lung cancer: case report.

D'Ambrosio DJ, Cohen RB, Glass J, Konski A, Buyyounouski MK, Feigenberg SJ.

J Neurooncol. 2007 Oct;85(1):77-9. Epub 2007 Apr 20.PMID: 17447010 [PubMed - indexed for MEDLINE]Related articles

Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1.

Tolcher AW, Mita M, Meropol NJ, von Mehren M, Patnaik A, Padavic K, Hill M, Mays T, McCoy T, Fox NL, Halpern W, Corey A, Cohen RB.

J Clin Oncol. 2007 Apr 10;25(11):1390-5. Erratum in: J Clin Oncol. 2007 Oct 10;25(29):4701. PMID: 17416859 [PubMed - indexed for MEDLINE]Related articles

EGFR-targeting monoclonal antibodies in head and neck cancer.

Astsaturov I, Cohen RB, Harari PM.

Curr Cancer Drug Targets. 2006 Dec;6(8):691-710. Review.PMID: 17168674 [PubMed - indexed for MEDLINE]Related articles

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).

Cohen RB, Langer CJ, Simon GR, Eisenberg PD, Hainsworth JD, Madajewicz S, Cosgriff TM, Pierce K, Xu H, Liau K, Healey D.

Cancer Chemother Pharmacol. 2007 Jun;60(1):81-9. Epub 2006 Oct 10.PMID: 17031646 [PubMed - indexed for MEDLINE]Related articles

Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.

Astsaturov I, Cohen RB, Harari P.

Expert Rev Anticancer Ther. 2006 Sep;6(9):1179-93. Review.PMID: 17020453 [PubMed - indexed for MEDLINE]Related articles

A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors.

Gore L, Holden SN, Cohen RB, Morrow M, Pierson AS, O'Bryant CL, Persky M, Gustafson D, Mikule C, Zhang S, Palmer PA, Eckhardt SG.

Ann Oncol. 2006 Nov;17(11):1709-17. Epub 2006 Sep 15.PMID: 16980604 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.

Hurwitz HI, Cohen RB, McGovren JP, Hirawat S, Petros WP, Natsumeda Y, Yoshinari T.

Cancer Chemother Pharmacol. 2007 Jan;59(1):139-47. Epub 2006 Jul 4.PMID: 16819636 [PubMed - indexed for MEDLINE]Related articles

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours.

Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC, Shaw DE, Mazar AP, Cohen RB.

Br J Cancer. 2006 Jun 5;94(11):1621-6.PMID: 16705310 [PubMed - indexed for MEDLINE]Related articlesFree article

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK.

N Engl J Med. 2006 Feb 9;354(6):567-78.PMID: 16467544 [PubMed - indexed for MEDLINE]Related articlesFree article

Targeting signal transduction pathways in colorectal cancer--more than skin deep.

Cohen SJ, Cohen RB, Meropol NJ.

J Clin Oncol. 2005 Aug 10;23(23):5374-85. Epub 2005 Jul 5. Review.PMID: 15998904 [PubMed - indexed for MEDLINE]Related articles

Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.

Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ.

Head Neck. 2005 May;27(5):406-14.PMID: 15719391 [PubMed - indexed for MEDLINE]Related articles

Phase II evaluation of 96-hour paclitaxel infusion in advanced (recurrent or metastatic) squamous cell carcinoma of the head and neck (E3395): a trial of the Eastern Cooperative Oncology Group.

Langer CJ, Li Y, Jennings T, DeConti RC, Nair S, Cohen RB, Forastiere AA; Eastern Cooperative Oncology Group.

Cancer Invest. 2004;22(6):823-31.PMID: 15641479 [PubMed - indexed for MEDLINE]Related articles

Toothpaste abrasion.

Cohen RB.

J Am Dent Assoc. 2004 Nov;135(11):1520, 1522; author reply 1522. No abstract available. PMID: 15622655 [PubMed - indexed for MEDLINE]Related articlesFree article

Epidermal growth factor receptor as a therapeutic target in colorectal cancer.

Cohen RB.

Clin Colorectal Cancer. 2003 Feb;2(4):246-51. Review.PMID: 12620146 [PubMed - indexed for MEDLINE]Related articles

Use of the aromatase inhibitor anastrozole in the treatment of patients with advanced prostate carcinoma.

Santen RJ, Petroni GR, Fisch MJ, Myers CE, Theodorescu D, Cohen RB.

Cancer. 2001 Oct 15;92(8):2095-101.PMID: 11596025 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-TNF therapy and malignancy - a critical review.

Cohen RB, Dittrich KA.

Can J Gastroenterol. 2001 Jun;15(6):376-84. Review.PMID: 11429667 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I study of weekly vinorelbine in combination with weekly paclitaxel in adult patients with advanced refractory cancer.

Cohen RB, Mueller SC, Haden K, de Souza P.

Cancer Invest. 2000;18(5):422-8.PMID: 10834026 [PubMed - indexed for MEDLINE]Related articles

Causes of failure among cuspal-coverage amalgam restorations: a clinical survey.

McDaniel RJ, Davis RD, Murchison DF, Cohen RB.

J Am Dent Assoc. 2000 Feb;131(2):173-7.PMID: 10680384 [PubMed - indexed for MEDLINE]Related articlesFree article

The relationship between infliximab treatment and lymphoma in Crohn's disease.

Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F.

Gastroenterology. 1999 Dec;117(6):1433-7. Review.PMID: 10579985 [PubMed - indexed for MEDLINE]Related articles

HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients.

Pinto LA, Berzofsky JA, Fowke KR, Little RF, Merced-Galindez F, Humphrey R, Ahlers J, Dunlop N, Cohen RB, Steinberg SM, Nara P, Shearer GM, Yarchoan R.

AIDS. 1999 Oct 22;13(15):2003-12.PMID: 10546852 [PubMed - indexed for MEDLINE]Related articles

Fracture strength of Class 2 amalgams with various cavity-lining materials.

Palmer AE, Davis RD, Murchison DF, Cohen RB.

Oper Dent. 1999 Jan-Feb;24(1):45-50.PMID: 10337298 [PubMed - indexed for MEDLINE]Related articles

Evidence of acute stress disorder after diagnosis of cancer.

McGarvey EL, Canterbury RJ, Cohen RB.

South Med J. 1998 Sep;91(9):864-6.PMID: 9743061 [PubMed - indexed for MEDLINE]Related articles